Lewy bodies (LB) and Lewy neurites (LN), which are primarily composed of α-synuclein (α-syn), are neuropathological hallmarks of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). We recently found that the neuronal phosphoprotein synapsin III (syn III) controls dopamine release via cooperation with α-syn and modulates α-syn aggregation. Here, we observed that LB and LN, in the substantia nigra of PD patients and hippocampus of one subject with DLB, displayed a marked immunopositivity for syn III. The in situ proximity ligation assay revealed the accumulation of numerous proteinase K-resistant neuropathological inclusions that contained both α-syn and syn III in tight association in the brain of affected subjects. Most strikingly, syn III was identified as a component of α-syn-positive fibrils in LB-enriched protein extracts from PD brains. Finally, a positive correlation between syn III and α-syn levels was detected in the caudate putamen of PD subjects. Collectively, these findings indicate that syn III is a crucial α-syn interactant and a key component of LB fibrils in the brain of patients affected by PD

Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains

Longhena Francesca;Faustini Gaia;Zaltieri Michela;Porrini Vanessa;Poliani Pietro Luigi;Missale Cristina;Borroni Barbara;Padovani Alessandro;Pizzi Marina;Spano PierFranco;Bellucci Arianna
2018-01-01

Abstract

Lewy bodies (LB) and Lewy neurites (LN), which are primarily composed of α-synuclein (α-syn), are neuropathological hallmarks of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). We recently found that the neuronal phosphoprotein synapsin III (syn III) controls dopamine release via cooperation with α-syn and modulates α-syn aggregation. Here, we observed that LB and LN, in the substantia nigra of PD patients and hippocampus of one subject with DLB, displayed a marked immunopositivity for syn III. The in situ proximity ligation assay revealed the accumulation of numerous proteinase K-resistant neuropathological inclusions that contained both α-syn and syn III in tight association in the brain of affected subjects. Most strikingly, syn III was identified as a component of α-syn-positive fibrils in LB-enriched protein extracts from PD brains. Finally, a positive correlation between syn III and α-syn levels was detected in the caudate putamen of PD subjects. Collectively, these findings indicate that syn III is a crucial α-syn interactant and a key component of LB fibrils in the brain of patients affected by PD
2018
2017
Sogg. privati ital. no profit
LS5_11 Neurological disorders (e.g. Alzheimer's disease, Huntington's disease, Parkinson's disease)
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
28
6
875
888
Lewy bodies, Lewy body dementia, Parkinson’s disease, alpha-synuclein, synapsin III
Altre fonti
14
info:eu-repo/semantics/article
262
Longhena, Francesca; Faustini, Gaia; Varanita, Tatiana; Zaltieri, Michela; Porrini, Vanessa; Tessari, Isabella; Poliani, Pietro Luigi; Missale, Cristi...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
reserved
File in questo prodotto:
File Dimensione Formato  
Longhena et al BPA 2018.pdf

gestori archivio

Tipologia: Documento in Pre-print
Licenza: DRM non definito
Dimensione 1.48 MB
Formato Adobe PDF
1.48 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/502087
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 43
social impact